Neo Ivy Capital Management - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q2 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q1 2022$156,000
+81.4%
6,212
+162.7%
0.14%
+14.6%
Q4 2021$86,000
-58.5%
2,365
-29.2%
0.12%
-46.8%
Q4 2020$207,000
+6800.0%
3,340
+4885.1%
0.23%
+7600.0%
Q3 2020$3,000
-98.0%
67
-98.2%
0.00%
-98.7%
Q1 2020$147,0003,6470.24%
Other shareholders
CHEMOCENTRYX INC shareholders Q2 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 545,532$13,518,0005.54%
Integral Health Asset Management, LLC 574,029$14,224,0002.93%
HealthCor Management, L.P. 1,097,370$27,193,0002.73%
Logos Global Management LP 600,000$14,868,0002.73%
Cormorant Asset Management, LP 1,425,000$35,312,0002.67%
Altium Capital Management LP 160,000$3,965,0001.59%
Cahill Wealth Management, LLC 68,358$1,693,0001.43%
Hood River Capital Management LLC 1,336,776$33,125,0001.32%
Sofinnova Investments, Inc. 636,659$15,776,0001.31%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 3,000$121,100,0001.26%
View complete list of CHEMOCENTRYX INC shareholders